- Research article
- Open Access
Microorganisms involved in deep neck infection (DNIs) in Greece: detection, identification and susceptibility to antimicrobials
BMC Infectious Diseases volume 19, Article number: 850 (2019)
To determine, from October 2010 to October 2018, the epidemiology of Deep Neck Infections (DNIs), regarding the detection, the identification and the susceptibility to antimicrobials of causative microorganisms, in Thessaly-Central Greece.
An analysis of data from a prospective database was conducted on 610 consecutive patients with DNIs treated in the Otolaryngology / Head & Neck Surgery Department of University Hospital of Larissa. Demographics, clinical features and microbiological data were analyzed.
Among the 610 patients (1,9/1 male to female ratio, mean age: 39,24 ± 17,25) with DNIs, 579 had a single space (94,9%), while the remaining 31 had a multi-space (5,1%) DNI. The most common areas affected were the peritonsillar space (84,6%) followed by the submandibular space (6,5%). Clinical samples were obtained from 462 patients, and were tested by culture and by the application of 16S rRNA PCR. Two hundred fifty-five samples (55,2%) gave positive cultures, in which Streptococcus pyogenes and Staphylococcus aureus were predominant. The application of the 16S rRNA PCR revealed that 183 samples (39,6%) were positive for bacterial DNA; 22 of them, culture negative, were found to be positive for anaerobic (Fusobacterium necrophorum, Actinomyces israellii etc) and for fastidious microorganisms (Brucella mellitensis, Mycobacterium avium).
DNIs represent a medical and surgical emergency and evidence-guided empirical treatment with intravenous infusion of antibiotics at the time of diagnosis is mandatory, highlighting the importance of epidemiological studies regarding the causative microorganisms. Although, in our study, the predominant pathogens were S. pyogenes and S. aureus, the combination of culture and molecular assay revealed that anaerobic bacteria play also a significant role in the pathogenesis of DNIs. Based on the local epidemiology, we propose as empirical therapy the intravenous use of a beta-lactam /beta-lactamase inhibitor; metronidazole or clindamycin can be added only in specific cases such as in immunocompromised patients.
Deep neck infections (DNIs) are defined by the presence of inflammation with or without pus in the deep spaces and fasciae of the head and neck. DNIs can be categorized into parapharyngeal, infratemporal, pterygomaxillary, temporal, parotid, masticator, submandibular, visceral, carotid sheath, peritonsillar-pharyngeal mucosal, retropharyngeal, danger and prevertebral spaces [1,2,3]. Despite the improvements of diagnostic tools (imaging and microbiological techniques), DNIs continue to be fatal, especially in immunocompromised patients or patients with significant co-morbidities . Their severity and extent can be overlooked, often masquerading other infections (i.e. pharyngitis, tonsillitis, torticollis etc), thus leading to delayed diagnosis .
Adult DNIs more commonly involve multiple spaces, leading to severe complications and appear to be more serious compared to children . In addition, use of analgesic, anti-inflammatory drugs and corticosteroids may mask presentations by blunting immune responses. It is sometimes difficult to trace the origin of the infection, since the primary source of infection may precede by weeks, given that the clinical manifestations are diverse and depend on the affected spaces . Even today, DNIs continue to be fatal, leading to life-threatening complications such as airway compromise, pneumonia, pericarditis, jugular vein thrombosis, mediastinal involvement. Treatment principles consist of adequate resuscitation, with surgical drainage of the neck and management of complications, combined with appropriate antimicrobial therapy. Although it is better to obtain cultures before the antibiotic treatment, the patients often are empirically treated, according to local and international guidelines.
In Greece, antimicrobial agents used for the treatment of DNIs include the intravenous infusion, alone or in combination, of penicillin, amoxicillin plus clavulanic acid, ampicillin plus sulbactam, clindamycin and metronidazole. However, the emergence and the spread of multi-drug bacteria both in the nosocomial environment and in the community emphasizes the need for a large epidemiological survey focused on the etiology and on the susceptibility of microorganisms that are the causative agents of DNIs.
The purpose of this study was to determine, during an eight- years study period (October 2010–October 2018) the identification and the susceptibility to antimicrobials of microorganisms involved in DNIs in Central Greece, in order to avoid clinical failure and misuse of antibiotics.
Patients with DNIs
A study of data exported from a prospective database was conducted on 610 consecutive patients with DNI diagnosis, admitted from October 2010 until October 2018 in the Otolaryngology / Head & Neck Surgery Department of University Hospital of Larissa, which is the main tertiary hospital of Thessaly, Central Greece. Thessaly is a rural area of Greece with about 1.000.000 inhabitants. The diagnosis of deep neck abscess was suspected by clinical history and confirmed by Computed Tomography (CT) or surgery. Demographic data (name, age, gender, residence, occupation, travel, previous hospitalization) and clinical information (underlying disease, antibiotic therapy) of the patients were collected. Clinical samples were obtained, after admission and before starting antibiotic treatment, by needle aspiration or by sterile swab using the BD ESwab™ collection and transport system (Becton Dickinson) and were immediately sent to the Microbiological Laboratory. The purulent material was divided in two parts, one for Gram-stain and culture and one for molecular assay.
Conventional methods: gram-stain, culture, identification and antimicrobial susceptibility test
The specimens, after being tested by Gram-stain, were cultured on two blood agar plates (one aerobically and one anaerobically using BD BBL™ GasPak™ anaerobic), on Mc Conkey agar and on Sabouraud agar for 5 days at 37 °C. The identification of microorganisms to the species level and the susceptibility testing was performed by the VITEK®2 automated system (bioMérieux, Marcy-l’Étoile, France). MICs were interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) (http://www.eucast.org/clinical_breakpoints/).
Molecular methods: 16S rRNA PCR followed by sequencing analysis
In an effort to identify rapidly the causative agent of DNIs, application of the 16S rRNA PCR was performed directly to the specimens as previously reported . Briefly, DNA was extracted using a QI Amp DNA Mini kit (QIAGEN, Hilden, Germany), according to the instructions of the manufacturer. Then, the 16S rRNA gene was amplified using the universal primers 5΄-AGAGTTTGATCATGGCTCA-3΄ (forward; located at positions 8 to 27) and 5΄-ACGGCGACTGCTGCTGGCAC-3΄ (reverse; positions 531 to 514 Escherichia coli). In the case where a band of approximately 520 bp was obtained, PCR amplicons were sequenced in both directions in an ABI 3130 genetic analyzer and were compared with those submitted to GenBank and EMBL, using the BLAST algorithm.
All descriptive data were reported in percentages. 2 × 2 contingency tables and Chi-Square tests were used to assess potential correlations. Data analysis was performed with the SPSS 20 statistical software (IBM, Chicago, IL, USA) and values of p < 0.05 were considered as significant results.
Among the 610 patients with DNIs, 399 were male and 211 females (1,9/1 male to female ratio) with a mean age ± SD of 39,24 ± 17,25 years. Among them, 564 were adults (≥ 18 years old) and 46 children (< 18 years old). In adults single space involvement was noticed in 534 patients (94,7%), and multi-space involvement in 30 patients (5,3%) (in 14 patients DNIs were located in more than two neck spaces). Peritonsillar- pharyngeal mucosal was the most common space involved (88,3%) followed by submandibular space (7,2%). In children single space involvement was noticed in 45 patients (97,8%) and multi-space involvement in one patient (2,2%). Peritonsillar was the most common space involved (86,9%) followed by parapharyngeal space (6,5%) (Table 1).
All patients underwent either needle aspiration or surgical drainage; cultures were taken before the empirical antimicrobial therapy was started. In some cases the treatment was modified properly after the results of susceptibility testing. Specimens for microbiological analysis were obtained in 462 out of 610 patients (428 adults and 34 children), while 45,6% (210/462) of them (46,3% of adults and 35,3% of children) had taken antibiotics before admission (Table 2). The most frequently antibiotics used before admission were amoxicillin plus clavulanic acid and clarithromycin (peros); empirical therapy included intravenous infusion of ampicillin-sulbactam combined with metronidazole or clindamycin. We note that clinical samples for microbiological analysis were not taken from 148 patients (24%), due mainly to the insufficient purulent material.
From the 462 clinical specimens, 55,2% (255/462) yielded positive cultures, while in 3 clinical samples two different bacterial species were isolated; thus 258 bacterial species were totally collected (see Tables 3 and 4). Chi-Square tests did not demonstrate any significant difference (p > 0,05) between prior antibiotics uptake and positive or negative culture results (Table 5), maybe due to insufficient power. From the isolated bacteria species 91,9% (237/258) were aerobic and 8,1% (21/258) anaerobic. The most common aerobic bacteria were Streptococcus pyogenes (45,3%) and Staphylococcus aureus (26,7%). The most common anaerobic bacteria were Prevotella melaninogenica (2,7%) and Fusobacterium nucleatum (2,7%) (Table 3). No significant correlation was noted in culture positivity from adults vs. children (Pearson Chi-Square: 2301; P: 0,129 > 0.05 / Yate’s Continuity Correction: 1790; P: 0,181 > 0.05 / Fisher’s Exact Test: P: 0,153 > 0.05).
Regarding the susceptibility of aerobic Gram-positive cocci to beta-lactams, all streptococci as anticipated were susceptible to penicillin. Among staphylococci, 90% of S. aureus isolates were resistant to penicillin and 3,9% were methicillin-resistant (MRSA). High rate of resistance to macrolides and lincosamides were observed in both S. pyogenes and S. aureus isolates (17 and 19% respectively). Aerobic Gram-negative bacteria expressed a wild-type phenotype without additional acquired resistance mechanisms. Finally, all anaerobic bacteria which were isolated by culture, were susceptible to amoxicillin-clavulanic, ampicillin-sulbactam, clindamycin and metronidazole.
The application of 16S rRNA PCR directly to the specimens revealed the presence of bacterial DNA in 183 out 462 samples (39,6%). One hundred-fifty of them (82%) gave positive cultures; identification by sequencing analysis was in concordance with that obtained by conventional methods. Results obtained by this molecular method were available within 2 days after the sampling. In addition, among the 33 samples (18%), that were PCR positive but culture negative, 22 (12%) were found to be positive for DNA of fastidious microorganisms, such as Actinomyces israelii (11 out 22), F. necrophorum (8 out 22), Brucella melitensis (2 out 22) and Mycobacterium avium (1 out 22). Regarding the remaining 11 samples (6%), Sanger sequencing analysis failed to distinguish the microorganisms involved, given that a polymicrobial genetic pattern was obtained.
DNIs are potentially fatal and require an aggressive diagnostic and therapeutic management. In the pre-antibiotic era, pharyngeal/tonsillar infection were responsible for 70% of deep neck space infection [10, 11]. Usually, DNIs occur after previous uncontrolled infections such as tonsillitis, dental infections, surgery, head and neck trauma or lymphadenitis after upper airways infection [4, 12], while, it is sometimes difficult to find the origin of DNI because the primary source of infection may precede it by weeks .
The management of DNIs involve surgical or needle drainage of the abscess associated with the use of intravenous antibiotics [13,14,15]. DNIs require timely treatment with IV antibiotics at the time of diagnosis because of the rapidly progressive nature of these infections. Antibiotic therapy should be empirically initiated, based on local epidemiology, ideally before culture and sensitivity results are available . Until now, various empiric antibiotics for deep neck infection have been proposed [16,17,18,19,20,21]. This fact highlights the importance of epidemiological studies in DNIs microbiology, since these studies help to determine the proper empirical treatment in each geographical area. To our knowledge, this is the first study in Greece focused on the etiology of DNIs.
According to our epidemiology, we propose as empirical therapy the intravenous use of a beta-lactam /beta-lactamase inhibitor; metronidazole or clindamycin can be added only in specific cases such as in immunocompromised patients. Although clindamycin has a broad range of activity against aerobic Gram-positive cocci and anaerobic organisms, clinicians must be prudent with its usage due to the increased rate of resistance. On the other hand, metronidazole has excellent in vitro activity against most obligate anaerobic bacteria (Bacteroides, Fusobacterium, etc) but is inactive for Propionibacterium acnes and Actinomyces israelii.
In the present study, cultures have obtained from 462 patients; 252 were unimicrobial, 3 were polymicrobial and 207 were culture-negative. The microorganisms isolated were bacteria that were part of the pharyngeal flora such as S. pyogenes S. aureus, Streptococcus group C, Streptococcus anginosus, Fusobacterium spp. and Prevotella spp. Previous studies have also demonstrated that S. pyogenes, S. aureus, Streptococcus viridans and Haemophilus influenza are the most common bacterial species [22,23,24,25]. The most common bacteria isolated were S. pyogenes and S. aureus in adults and in children as well. Most studies report a lower prevalence of DNI in children compared to adults [3, 26, 27]. Probably this may be caused by the history of antibiotics abuse, especially in colds and other viral infections, which are more prevalent in children than in adults [28, 29]. In our study children comprised 5,6% of total patients. According to the literature, the effect of age on the distribution of bacteria causing DNI is not clear. Coticchia et al. have compared the bacteriology between patients less than 1 year and above 1 year of age and they have found that age was a significant factor influencing bacteriology of DNI . On the other hand, other authors did not find any significant differences in bacteriology of DNI between various age groups. We point out that the incidence of anaerobic bacteria was higher in adults compared to children.
Finally, interesting finding was that 16S rRNA PCR followed by sequencing analysis detected bacterial DNA in 33 specimens that gave culture-negative results; 19 of them were found to be positive for anaerobic bacteria such as A. israelii and F. necrophorum. Since none of these patients had taken antimicrobial therapy before admission, the failure of the conventional cultures to isolate these microorganisms could be related to the inappropriate sample collection combined with the fragility of the bacteria and the short incubation time of the anaerobic culture. In addition, 16S rRNA PCR identified correctly the causative microorganisms which were isolated from 150 samples, while, the results obtained by the molecular methods were available sooner than that obtained from cultures (mean time 2 versus 5 days). However, this molecular assay failed to detect bacterial DNA in 105 culture-positive samples, probably due to the low microbial load. It is known that the sensitivity of the 16S rRNA PCR, when it is applied directly to the clinical samples, is depending on the bacterial concentration. The culture of the low-microbial load clinical samples combined with an elongation of the time of incubation time enhances the growth of microorganisms, giving more positive results than the molecular method. Unfortunately, this molecular approach, which uses the 16S rRNA PCR combined with Sanger analysis, is not able to identify more than one microorganism per sample. Probably in the future, the implementation of the next generation sequencing technology could solve this limitation.
In conclusion, deep neck infections represent a medical and surgical emergency, they are still common and can develop serious complications. ‘Evidence-guided’ empirical treatment with IV antibiotics at the time of diagnosis is mandatory, highlighting the importance of epidemiological studies in DNIs microbiology. Although, in our study, the main pathogens were S. pyogenes and S. aureus, the combination of conventional and molecular assays revealed that anaerobic bacteria play also a significant role in the pathogenesis of DNIs. Based on the local epidemiology, we propose as empirical therapy the intravenous use of a beta-lactam /beta-lactamase inhibitor; metronidazole or clindamycin can be added only in specific cases such as in immunocompromised patients.
Availability of data and materials
The datasets are available by request to the corresponding author.
Deep neck infections
European Committee on Antimicrobial Susceptibility Testing
Polymerase chain reaction
Christian JM, Goddard AC, Gillespie MB. Deep neck and odontogenic infections, in cummings otolaryngology - head and neck surgery. 6th ed; 2015. p. 164–75.
Aygun Ν, Zinreich SJ. Overview of diagnostic imaging of the head and neck, in cummings otolaryngology - head and neck surgery. 6th ed; 2015. p. 104–53.
Santos Gorjón P, Blanco Pérez P, Morales Martín AC, Del Pozo de Dios JC, Estévez Alonso S, de la Cabanillas MI C. Deep neck infection. Review of 286 cases. Acta Otorrinolaringol Esp. 2012;63:31–41.
Sakagushi M, Sato S, Ishiyama T, Katsuno S, Tagushi K. Characterization and management of deep neck infection. Int J Oral Maxillofac Surg. 1997;26:131–4.
Raffaldi I, Le Serre D, Garazzino S, Scolfaro C, Bertaina C, Mignone F, et al. Diagnosis and management of deep neck infections in children: the experience of an Italian paediatric centre. J Infect Chemother. 2015;21:110–3.
Yang W, Hu L, Wang Z, Nie G, Li X, Lin D, et al. Deep neck infection: a review of 130 cases in Southern China. Medicine (Baltimore). 2015;94:e994.
Abdel-Haq NM, Harahsheh A, Asmar BL. Retropharyngeal abscess in children: the emerging role of group A beta hemolytic streptococcus. South Med J. 2006;99:927–31.
Lee JK, Kim HD, Lim SC. Predisposing factors of complicated deep neck infection: an analysis of 158 cases. Yonsei Med J. 2007;48:55–62.
Malli E, Gatselis NK, Dalekos GN, Petinaki E. Combination of vial culture and broad-range PCR for the diagnosis of spontaneous bacterial peritonitis: experience in a Greek tertiary care hospital. New Microbes New Infect. 2018;18(28):1–5.
Har-El G, Aroesty JH, Shaha A, Lucent FE. Changing trends in deep neck abscess. Oral Med Oral Pathol. 1994;77:446–50.
Lee YQ, Kanagalingam J. Deep neck abscesses: the Singapore experience. Eur Arch Otorhinolaryngol. 2011;268:609–14.
Fujiyoshi T, Yoshida M, Udaka T, Tanabe T, Makishima K. Clinical relevance of the Streptococcus milleri group in head and neck infections. Nihon Jibiinkoka Gakkai Kaiho. 2002;105:14–21.
Sethi DS, Stanley RE. Parapharyngeal abscesses. J Laryngol Otol. 1991;105:1025–30.
Miller WD, Furst IM, Sandor GKB, Keller MA. A prospective, blinded comparison of clinical examination and computed tomography in deep neck infections. Laryngoscope. 1999;109:1873–9.
Reynolds SC, Chow AW. Life-threatening infections of the peripharyngeal and deep fascial spaces of the head and neck. Infect Dis Clin N Am. 2007;21:557–76.
Yang SW, Lee MH, See LC, Huang SH, Chen TM, Chen TA. Deep neck abscess: an analysis of microbial etiology and the effectiveness of antibiotics. Infect Drug Resist. 2008;1:1–8.
Fairbanks D. Pocket guide to antimicrobial therapy in otolaryngology-head and neck surgery. 13th ed; 2007. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc
Marioni G, Staffieri A, Parisi S, Marchese-Ragona R, Zuccon A, Staffieri C, et al. Rational diagnostic and therapeutic management of deep neck infections: analysis of 233 consecutive cases. Ann Otol Rhinol Laryngol. 2010;119:181–7.
Motahari SJ, Poormoosa R, Nikkhah M, Bahari M, Shirazy SM, Khavarinejad F. Treatment and prognosis of deep neck infections. J Indian J Otolaryngol Head Neck Surg. 2015;67:134–7.
Wei D, Bi L, Zhu H, He J, Wang H. Less invasive management of deep neck infection and descending necrotizing mediastinitis: a single-center retrospective study. Medicine (Baltimore). 2017;96:e6590.
Varghese L, Mathews SS, Antony Jude Prakash J, Rupa V. Deep head and neck infections: outcome following empirical therapy with early generation antibiotics. Trop Dr. 2018;48:179–82.
Parhiscar A, Har-El G. Deep neck abscess: a retrospective review of 210 cases. Ann Otol Rhinol Laryngol. 2001;110:1051–4.
Sennes LU, Imamura R, Júnior FVA, Frizzarini R, Tsuji DH. Deep neck infections: prospective study of 57 patients. Rev Bras Otorrinolaringol. 2002;68:388–93.
Martínez Pascual P, Pinacho Martinez P, Friedlander E, Martin Oviedo C, Scola YB. Peritonsillar and deep neck infections: a review of 330 cases. Braz J Otolaryngol. 2018;84:305–10.
Prabhu SR, Nirmalkumar ES. Acute fascial space infections of the Neck: 1034 cases in 17 years follow up. Ann Maxillofac Surg. 2019;9:118–23.
Brito TP, Hazboun IM, Fernandes FL, Bento LR, Zappelini CEM, Chone CT, et al. Deep neck abscesses: study of 101 cases. Braz J Otorhinolaryngol. 2017;83:341.
Huang CM, Huang FL, Chien YL, Chen PY. Deep neck infections in children. J Microbiol Immunol Infect. 2017;50:627–33.
Monto AS. Studies of the community and family: acute respiratory illness and infection. Epidemiol Rev. 1994;16:351–73.
Heikkinen T, Jarvinen A. The common cold. Lancet. 2003;361:51–9.
Coticchia JM, Getnick GS, Yun RD, Arnold JE. Age-, site-, and time-specific differences in pediatric deep neck abscesses. Arch Otolaryngol Head Neck Surg. 2004;130:201–7.
None to declare
None to declare
Ethics approval and consent to participate
The research protocol was approved by the Ethics Committee of the General University Hospital of Larissa (Research Code Number: 388). This research involves no human subjects, human material (tissue), or human data. The clinical isolates and the data were collected as part of routine microbiology laboratory diagnostics without any identifiable information of patients.
Consent for publication
EP is member of the Editorial Board of the BMC Infectious Diseases.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Beka, D., Lachanas, V.A., Doumas, S. et al. Microorganisms involved in deep neck infection (DNIs) in Greece: detection, identification and susceptibility to antimicrobials. BMC Infect Dis 19, 850 (2019). https://doi.org/10.1186/s12879-019-4476-3
- Neck abscesses
- Neck infection
- Neck spaces
- Causative agents